ETF Managers Group, LLC Organon & Co. Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 23, 2023	BUY	$23.31 - $28.61 $1.17 Million - $1.44 Million	50,169 Added 918.85%	55,629 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $483,397 - $707,536	-20,658 Reduced 79.09%	5,460 $128,000
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $798,021 - $980,513	25,206 Added 2763.82%	26,118 $903,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $639 - $826	21 Added 2.36%	912 $33,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $1,204 - $1,559	42 Added 4.95%	891 $27,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $2,032 - $2,530	71 Added 9.13%	849 $29,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $22,134 - $29,564	778 New	778 $24,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.